Israel Corp. Reports Results for Second Quarter of 2025
MWN-AI** Summary
Israel Corporation Ltd. (TASE: ILCO) released its financial results for the second quarter of 2025, showing a mixed performance compared to the same period last year. For Q2 2025, the company reported a net profit of $43 million, a slight decrease from $48 million in Q2 2024. The company's share in ICL profits dropped to $40 million from $50 million, while its share in Prodalim's profits turned positive with $2 million, up from a previous loss.
The financial liabilities of ILCO stood at $715 million, contrasted by liquid asset investments totaling $739 million, resulting in a net cash position of $26 million, an increase from $21 million at the end of Q1 2025. The net cash figure incorporates the fair value of derivatives, which lowered the economic value of financial liabilities.
Notably, Israel Corp acquired a 27.5% stake in Prodalim Investments, emphasizing its strategic investment in a company focused on natural solutions across various industries, including innovations in de-alcoholization of beverages. This investment falls in line with ILCO's strategy to expand its portfolio, particularly in food tech, agriculture tech, healthcare, and Industry 4.0 sectors.
The Board of Directors also announced a dividend distribution of $15 million in April as per the company’s ongoing dividend policy. Overall, the performance reflects an adaptive approach to market dynamics, though the slight drop in profits raises questions for investors regarding profitability in a competitive environment. Israel Corporation continues to maintain a strong asset base, with total assets reported at $4.07 billion by the end of June 2025, upholding its position as a significant player on the Tel Aviv Stock Exchange.
MWN-AI** Analysis
Israel Corporation Ltd. (TASE: ILCO) reported its second-quarter results for 2025, revealing a resilient performance despite some fluctuations in key metrics. The company's share in ICL's profit decreased to $40 million from $50 million year-over-year, while dividends remain stable, showcasing management's commitment to returning value to shareholders. However, the decline in profits necessitates a closer examination of underlying drivers, especially considering the amortization expenses and adjustments affecting profitability at the headquarters level.
Liquidity remains robust, evidenced by a net cash position of $26 million, reflecting a healthy balance sheet. The completion of the investment agreement with Prodalim, now accounting for approximately 27.5% of its share capital, positions ILCO well within the lucrative natural products sector. Prodalim’s focus on innovative solutions, particularly in the de-alcoholization of beverages, taps into evolving consumer preferences, indicating potential for growth.
As analysts assess ILCO's strategic direction, the emphasis on sectors such as food tech, agriculture tech, and healthcare aligns with global trends toward sustainability and health-conscious consumerism. The company's diverse portfolio, highlighted by its stakes in ICL and AKVA Group, reinforces its position in established markets while enhancing resilience against sector-specific downturns.
Looking forward, it may be prudent for investors to monitor developments in company operations closely. While the structural investments in high-potential sectors are promising, caution is warranted given the recent fluctuations in profit contributions from key investees. Stakeholders should also keep an eye on broader market conditions impacting the commodities and industrial sectors tied to ICL and AKVA.
In conclusion, maintaining a diversified investment stance within ILCO could be beneficial, while considering potential volatility. A focus on the upcoming strategic endeavors, especially those stemming from Prodalim's innovations, positions ILCO for potential long-term growth, making it a stock worth monitoring in the evolving market landscape.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
TEL AVIV, Israel , Aug. 13, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its second quarter results for the period ending June 30, 2025 .
Selected Financial Figures for the Second Quarter 2025: | ||
| Q 2 /2 5 | Q 2 / 24 |
ILCO share in ICL profit | 40 | 50 |
ILCO share in Prodalim profit | 2 | - |
Amortization of excess cost in held companies | (2) | (1) |
Financing, G&A and other at ILCO headquarter level | 2 | (1) |
Tax income of ILCO Headquarters | 1 | - |
Net profit to company's shareholders | 43 | 48 |
Liquidity at the ILCO Headquarters Level [1]
As of June 30, 2025 , total financial liabilities were $715 million , and investments in liquid assets amounted to $739 million of which $8 million are pledged deposits.
Net cash 1 as of June 30, 2025 , totaled $26 million . The net cash includes the fair value of derivatives transactions, which decreases the economic value of the financial liabilities by $2 million . As of March 31, 2025 , the net cash was $21 million .
Additional updates
On March 5, 2025 , ILCO completed the investment agreement with Prodalim Investments Ltd, ("Prodalim"), dated January 21, 2025 , after the completion of the transaction, ILCO holds approximately 27.5% of Prodalim's share capital, on a fully diluted basis. Prodalim is a private company, incorporated in Israel , which is engaged in creating natural solutions for various industries. Its products include concentrates, flavors and fragrances, beverage bases and other natural functional ingredients. In addition, Prodalim is developing innovative activities focused on the emerging world of the de-alcoholization of alcoholic beverages*
On March 27, 2025 , ILCO Board of Directors decided on distribution of dividend at the sum of $15m , this in accordance with the company's dividend policy announced in January 2023 . The record date was April 9, 2025 , and the payment date was April 21, 2025 .
ILCO financial results of ILCO are mainly affected by the results of its investees. For more details see detailed financial report.
ILCO Total Assets, Net | |
| 30/06/2025 |
Assets | |
ICL (~567m shares, market value) | 3,883 |
Prodalim (cost) | 118 |
AKVA Group (~6.6m shares, market value) | 54 |
Other [2] | 15 |
Total Assets | 4,070 |
ILCO's Net Cash | 26 |
Total Assets, net | 4,096 |
About Israel Corporation
Israel Corporation Ltd. (TASE: ILCO) ("ILCO") is a reputable public investment company, which owns and invests in high quality companies with established managements and go-to markets.
In November 2019 , ILCO announced its updated strategy, ILCO plans to expand its portfolio through new investments over the next few years. ILCO plans to focus mainly on the food (inc. tech), agriculture (inc. tech), healthcare and industry 4.0 sectors. For more details please see the following link to ILCO updated Strategy Presentation
ILCO strives to generate return on its investment through active board participations and its operational and managerial expertise.
ILCO current core holdings include c.44% stake in ICL Group (NYSE:ICL, TASE:ICL), c.18% stake in AKVA Group (OB:AKVA) and c.27.5% in Prodalim (on a fully diluted basis).
ILCO is publicly traded on the Tel Aviv Stock Exchange under the ticker ILCO and is included in the TA-35 Index.
For further information on ILCO, see ILCO's publicly available filings, which can be found on the Tel Aviv Stock Exchange website at http://maya.tase.co.il .
Please also see ILCO company website http://www.israelcorp.com for additional information.
Convenience Translation
The financial information found in this press release is an English summary based on the original Hebrew financial statements and is solely for the convenience of the reader. The binding version is the original in Hebrew.
Forward Looking Statements
This press release may contain forward-looking statements, which may not materialize and are subject to risks and uncertainties that are not under the control of ILCO, which may cause actual results to differ materially from those contained in the disclosures.
Investor Relations Contacts
Idan Hizki
Vice President, Business Development
Tel: +972 3 684 4500
idanh@israelcorp.com
[1] Israel Corp and its wholly owned and controlled headquarter companies.
[2] Includes 1.983m shares in Nordic Aqua Partners (OB:NOAP).
SOURCE Israel Corporation Ltd.
FAQ**
How does Israel Corp. Ltd. IRLCF plan to address the decline in profit share from ICL, which fell from $50 million in Q2 2024 to $40 million in Q2 2025, and what strategies are in place to optimize this investment moving forward?
In light of the recent investment in Prodalim, what specific contributions to revenue and profit does Israel Corp. Ltd. IRLCF anticipate from this venture, particularly in the development of de-alcoholization technologies for beverages?
Given the increase in net cash from $21 million in Q1 2025 to $26 million in Q2 2025, what are the key factors driving this liquidity and how does Israel Corp. Ltd. IRLCF intend to utilize this cash in the upcoming quarters?
With the company's ongoing strategy to expand its portfolio in sectors like food and healthcare, how does Israel Corp. Ltd. IRLCF prioritize potential investments, especially considering its recent dividend distribution of $15 million?
**MWN-AI FAQ is based on asking OpenAI questions about Israel Corporation Ltd (OTC: IRLCF).
NASDAQ: IRLCF
IRLCF Trading
2485.27% G/L:
$238 Last:
7 Volume:
$238 Open:
